200 related articles for article (PubMed ID: 16256161)
1. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
3. The immune response to vaccinia virus is significantly reduced after scarification with TK- recombinants as compared to wild-type virus.
Phillpotts RJ; Lescott T; Gates AJ; Jones L
Acta Virol; 2000; 44(3):151-6. PubMed ID: 11155357
[TBL] [Abstract][Full Text] [Related]
4. Controlling orthopoxvirus infections--200 years after Jenner's revolutionary immunization.
Niemiałtowski MG; Toka FN; Malicka E; Gieryńska ; Spohr de Faundez I; Schollenberger A
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):373-8. PubMed ID: 9017154
[TBL] [Abstract][Full Text] [Related]
5. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
[TBL] [Abstract][Full Text] [Related]
7. [Development of a numerically additive combined vaccine against tetanus and smallpox].
Mayr A; Baljer G; Wagner C; Sailer J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
[TBL] [Abstract][Full Text] [Related]
8. [Aerosol vaccination against mousepox (infectious ectromelia) in comparison with other vaccination methods using vaccinia and mousepox vaccines].
Munz E; Reimann M; Zschekel WD
Zentralbl Veterinarmed B; 1976 Jun; 23(5-6):431-46. PubMed ID: 183420
[No Abstract] [Full Text] [Related]
9. Pathogenesis of vaccinia (IHD-T) virus infection in BALB/cAnN mice.
Jacoby RO; Bhatt PN; Johnson EA; Paturzo FX
Lab Anim Sci; 1983 Oct; 33(5):435-41. PubMed ID: 6316026
[TBL] [Abstract][Full Text] [Related]
10. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
Hooper JW; Custer DM; Thompson E
Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
[TBL] [Abstract][Full Text] [Related]
11. Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus.
Kroeger MA; McMinn PC
Arch Virol; 2002 Jun; 147(6):1155-72. PubMed ID: 12111426
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination against mouse pox].
Mahnel H
Tierarztl Prax; 1985; 13(3):403-7. PubMed ID: 3000022
[TBL] [Abstract][Full Text] [Related]
13. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
[TBL] [Abstract][Full Text] [Related]
14. The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.
Thornton B
Br J Exp Pathol; 1980 Aug; 61(4):444-50. PubMed ID: 7426394
[TBL] [Abstract][Full Text] [Related]
15. Reexamination of the efficacy of vaccination against mousepox.
Buller RM; Wallace GD
Lab Anim Sci; 1985 Oct; 35(5):473-6. PubMed ID: 2997541
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
Gardner I; Bowern NA; Blanden RV
Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
[No Abstract] [Full Text] [Related]
17. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
Stern RJ; Thompson JP; Moyer RW
Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
[TBL] [Abstract][Full Text] [Related]
18. Mousepox outbreak in a laboratory mouse colony.
Dick EJ; Kittell CL; Meyer H; Farrar PL; Ropp SL; Esposito JJ; Buller RM; Neubauer H; Kang YH; McKee AE
Lab Anim Sci; 1996 Dec; 46(6):602-11. PubMed ID: 9001171
[TBL] [Abstract][Full Text] [Related]
19. [The resistance of a maternally-derived immunity of baby mice against mousepox--experiments regarding a special possibility of immunization with orthopox viruses (author's transl)].
Munz E; Reimann M; Kaufmann R
Zentralbl Bakteriol B; 1979; 169(5-6):495-509. PubMed ID: 232602
[TBL] [Abstract][Full Text] [Related]
20. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Law M; Smith GL
Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
